PHARMING GRP SP. ADRS Net Asset Quality Index
PHARMING GRP SP. ADRS net asset quality index. PHARMING GRP SP. ADRS (PHG) has a Net Asset Quality Index of 55.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €499.96 Million minus total liabilities of €222.86 Million yields net assets of €277.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check PHG cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of PHARMING GRP SP. ADRS (2021–2025)
Net asset quality index of PHARMING GRP SP. ADRS from 2021 to 2025. This chart shows how PHARMING GRP SP. ADRS's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 55.4%, representing net assets of €277.10 Million against total assets of €499.96 Million EUR. See PHARMING GRP SP. ADRS net assets for net asset value and shareholders' equity analysis.
PHARMING GRP SP. ADRS Net Asset Quality Index by Year (2021–2025)
PHARMING GRP SP. ADRS net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PHG stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.4% | €277.10 Million | €499.96 Million | €222.86 Million | ▲ +0.2 pp |
| 2024 | 55.3% | €221.06 Million | €399.99 Million | €178.92 Million | ▲ +8.0 pp |
| 2023 | 47.3% | €218.78 Million | €462.85 Million | €244.07 Million | ▼ -0.8 pp |
| 2022 | 48.1% | €204.64 Million | €425.80 Million | €221.16 Million | ▼ -0.5 pp |
| 2021 | 48.6% | €192.92 Million | €397.31 Million | €204.40 Million | — |